Legal Representation
Attorney
Jeffrey S. Ward
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 16, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 16, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 16, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 30, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 24, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 23, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 19, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 19, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 18, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 28, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| May 28, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 28, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 19, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 13, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 13, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 23, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 22, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 22, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 17, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 5, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 3, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 3, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 3, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 7, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 5, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 5, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 5, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 3, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 3, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 26, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 24, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 24, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 24, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 7, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 5, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 5, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 5, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 26, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 1, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 1, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 12, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 15, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 14, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 14, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 16, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 16, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 16, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes
First Use Anywhere:
Apr 24, 2020
First Use in Commerce:
Apr 24, 2020
Additional Information
Design Mark
The mark consists of a stylized "M" inside a circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005